by UC Davis Credit: CC0 Public Domain A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers at the University of California, Davis. A paper describing the work is published Dec. 9 in Nature. “Psychedelics are some of the most powerful drugs we...